{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:46:35Z","timestamp":1794645995586,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41590-025-02288-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:06:06Z","timestamp":1759136766000},"page":"1962-1976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections"],"prefix":"10.1038","volume":"26","author":[{"given":"Clemence","family":"Ngo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Pierini-Malosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalissa","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Collinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Bessou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Guerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Fabregue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solene","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sharkaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6516-2064","authenticated-orcid":false,"given":"Sophie","family":"Mazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Sansoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-6594","authenticated-orcid":false,"given":"Frederic","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Laprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4619-697X","authenticated-orcid":false,"given":"Lena","family":"Alexopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wurbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9jane","family":"Rua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjess","family":"Haidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-5358","authenticated-orcid":false,"given":"Pierre","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Escali\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien Phong","family":"Vu Manh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Fallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Chasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Baranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-3800","authenticated-orcid":false,"given":"Marc","family":"Le Bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-9342","authenticated-orcid":false,"given":"Bernard","family":"Malissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5488-4137","authenticated-orcid":false,"given":"Ana","family":"Zarubica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6436-7966","authenticated-orcid":false,"given":"Marc","family":"Dalod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6839-5219","authenticated-orcid":false,"given":"Elena","family":"Tomasello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2288_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3389\/fimmu.2014.00526","volume":"5","author":"E Tomasello","year":"2014","unstructured":"Tomasello, E., Pollet, E., Vu Manh, T. P., Uze, G. & Dalod, M. Harnessing mechanistic knowledge on beneficial versus deleterious IFN-I effects to design innovative immunotherapies targeting cytokine activity to specific cell types. Front. Immunol. 5, 526 (2014).","journal-title":"Front. Immunol."},{"key":"2288_CR2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","volume":"369","author":"A Broggi","year":"2020","unstructured":"Broggi, A. et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 369, 706\u2013712 (2020).","journal-title":"Science"},{"key":"2288_CR3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.abc2061","volume":"369","author":"J Major","year":"2020","unstructured":"Major, J. et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science 369, 712\u2013717 (2020).","journal-title":"Science"},{"key":"2288_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","volume":"50","author":"B Reizis","year":"2019","unstructured":"Reizis, B. Plasmacytoid dendritic cells: development, regulation, and function. Immunity 50, 37\u201350 (2019).","journal-title":"Immunity"},{"key":"2288_CR5","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41423-024-01167-5","volume":"21","author":"C Ngo","year":"2024","unstructured":"Ngo, C., Garrec, C., Tomasello, E. & Dalod, M. The role of plasmacytoid dendritic cells (pDCs) in tissue immunity during viral infections and beyond. Cell Mol. Immunol. 21, 1008\u20131035 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"2288_CR6","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.ppat.1001017","volume":"6","author":"G Bocharov","year":"2010","unstructured":"Bocharov, G. et al. A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections. PLoS Pathog. 6, e1001017 (2010).","journal-title":"PLoS Pathog."},{"key":"2288_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-031210-101345","volume":"29","author":"B Reizis","year":"2011","unstructured":"Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L. & Sisirak, V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29, 163\u2013183 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"2288_CR8","doi-asserted-by":"crossref","first-page":"e1008737","DOI":"10.1371\/journal.ppat.1008737","volume":"16","author":"M Sa Ribero","year":"2020","unstructured":"Sa Ribero, M., Jouvenet, N., Dreux, M. & Nisole, S. Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog. 16, e1008737 (2020).","journal-title":"PLoS Pathog."},{"key":"2288_CR9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1126\/science.1158298","volume":"321","author":"H von Bernuth","year":"2008","unstructured":"von Bernuth, H. et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321, 691\u2013696 (2008).","journal-title":"Science"},{"key":"2288_CR10","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.20070628","volume":"204","author":"CL Ku","year":"2007","unstructured":"Ku, C. L. et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204, 2407\u20132422 (2007).","journal-title":"J. Exp. Med."},{"key":"2288_CR11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1126\/science.abj7965","volume":"374","author":"JL Casanova","year":"2021","unstructured":"Casanova, J. L. & Abel, L. Mechanisms of viral inflammation and disease in humans. Science 374, 1080\u20131086 (2021).","journal-title":"Science"},{"key":"2288_CR12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.aaa1578","volume":"348","author":"MJ Ciancanelli","year":"2015","unstructured":"Ciancanelli, M. J. et al. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348, 448\u2013453 (2015).","journal-title":"Science"},{"key":"2288_CR13","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).","journal-title":"Science"},{"key":"2288_CR14","doi-asserted-by":"crossref","first-page":"e20220202","DOI":"10.1084\/jem.20220202","volume":"219","author":"TM Campbell","year":"2022","unstructured":"Campbell, T. M. et al. Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency. J. Exp. Med. 219, e20220202 (2022).","journal-title":"J. Exp. Med."},{"key":"2288_CR15","doi-asserted-by":"crossref","first-page":"e20220131","DOI":"10.1084\/jem.20220131","volume":"219","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. J. Exp. Med. 219, e20220131 (2022).","journal-title":"J. Exp. Med."},{"key":"2288_CR16","doi-asserted-by":"crossref","first-page":"eabl4348","DOI":"10.1126\/sciimmunol.abl4348","volume":"6","author":"T Asano","year":"2021","unstructured":"Asano, T. et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci. Immunol. 6, eabl4348 (2021).","journal-title":"Sci. Immunol."},{"key":"2288_CR17","doi-asserted-by":"crossref","first-page":"e20220170","DOI":"10.1084\/jem.20220170","volume":"220","author":"A Garcia-Garcia","year":"2023","unstructured":"Garcia-Garcia, A. et al. Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia. J. Exp. Med. 220, e20220170 (2023).","journal-title":"J. Exp. Med."},{"key":"2288_CR18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.cmi.2022.02.022","volume":"28","author":"TH Mogensen","year":"2022","unstructured":"Mogensen, T. H. Human genetics of SARS-CoV-2 infection and critical COVID-19. Clin. Microbiol Infect. 28, 1417\u20131421 (2022).","journal-title":"Clin. Microbiol Infect."},{"key":"2288_CR19","doi-asserted-by":"crossref","first-page":"e20212427","DOI":"10.1084\/jem.20212427","volume":"219","author":"CJA Duncan","year":"2022","unstructured":"Duncan, C. J. A. et al. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. J. Exp. Med. 219, e20212427 (2022).","journal-title":"J. Exp. Med."},{"key":"2288_CR20","doi-asserted-by":"crossref","first-page":"e1004897","DOI":"10.1371\/journal.ppat.1004897","volume":"11","author":"C Cocita","year":"2015","unstructured":"Cocita, C. et al. Natural killer cell sensing of infected cells compensates for MyD88 deficiency but not IFN-I activity in resistance to mouse cytomegalovirus. PLoS Pathog. 11, e1004897 (2015).","journal-title":"PLoS Pathog."},{"key":"2288_CR21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/eji.202149513","volume":"52","author":"M Dalod","year":"2022","unstructured":"Dalod, M. & Scheu, S. Dendritic cell functions in vivo: a user\u2019s guide to current and next- generation mutant mouse models. Eur. J. Immunol. 52, 1712\u20131749 (2022).","journal-title":"Eur. J. Immunol."},{"key":"2288_CR22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2010.11.020","volume":"33","author":"M Swiecki","year":"2010","unstructured":"Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y. & Colonna, M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33, 955\u2013966 (2010).","journal-title":"Immunity"},{"key":"2288_CR23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbi.2021.04.018","volume":"95","author":"S Stutte","year":"2021","unstructured":"Stutte, S. et al. Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in mice. Brain Behav. Immun. 95, 429\u2013443 (2021).","journal-title":"Brain Behav. Immun."},{"key":"2288_CR24","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1371\/journal.ppat.0020053","volume":"2","author":"R Le Goffic","year":"2006","unstructured":"Le Goffic, R. et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2, e53 (2006).","journal-title":"PLoS Pathog."},{"key":"2288_CR25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41590-023-01454-9","volume":"24","author":"M Valente","year":"2023","unstructured":"Valente, M. et al. Novel mouse models based on intersectional genetics to identify and characterize plasmacytoid dendritic cells. Nat. Immunol. 24, 714\u2013728 (2023).","journal-title":"Nat. Immunol."},{"key":"2288_CR26","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1016\/j.celrep.2019.11.042","volume":"29","author":"R Leylek","year":"2019","unstructured":"Leylek, R. et al. Integrated cross-species analysis identifies a conserved transitional dendritic cell population. Cell Rep. 29, 3736\u20133750 e3738 (2019).","journal-title":"Cell Rep."},{"key":"2288_CR27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s41590-023-01545-7","volume":"24","author":"FB Sulczewski","year":"2023","unstructured":"Sulczewski, F. B. et al. Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses. Nat. Immunol. 24, 1265\u20131280 (2023).","journal-title":"Nat. Immunol."},{"key":"2288_CR28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20011672","volume":"195","author":"M Dalod","year":"2002","unstructured":"Dalod, M. et al. Interferon \u03b1\/\u03b2 and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195, 517\u2013528 (2002).","journal-title":"J. Exp. Med."},{"key":"2288_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/intimm\/dxm119","volume":"20","author":"N Zucchini","year":"2008","unstructured":"Zucchini, N. et al. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int Immunol. 20, 45\u201356 (2008).","journal-title":"Int Immunol."},{"key":"2288_CR30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41590-020-0731-4","volume":"21","author":"A Abbas","year":"2020","unstructured":"Abbas, A. et al. The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection. Nat. Immunol. 21, 983\u2013997 (2020).","journal-title":"Nat. Immunol."},{"key":"2288_CR31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1084\/jem.20021522","volume":"197","author":"M Dalod","year":"2003","unstructured":"Dalod, M. et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon \u03b1\/\u03b2. J. Exp. Med. 197, 885\u2013898 (2003).","journal-title":"J. Exp. Med."},{"key":"2288_CR32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/eji.200838814","volume":"39","author":"C Steinberg","year":"2009","unstructured":"Steinberg, C. et al. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection. Eur. J. Immunol. 39, 1007\u20131018 (2009).","journal-title":"Eur. J. Immunol."},{"key":"2288_CR33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.chom.2012.09.002","volume":"12","author":"T Baranek","year":"2012","unstructured":"Baranek, T. et al. Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe 12, 571\u2013584 (2012).","journal-title":"Cell Host Microbe"},{"key":"2288_CR34","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1084\/jem.20071365","volume":"205","author":"CH GeurtsvanKessel","year":"2008","unstructured":"GeurtsvanKessel, C. H. et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b\u2212 but not plasmacytoid dendritic cells. J. Exp. Med. 205, 1621\u20131634 (2008).","journal-title":"J. Exp. Med."},{"key":"2288_CR35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4049\/jimmunol.182.2.871","volume":"182","author":"AI Wolf","year":"2009","unstructured":"Wolf, A. I. et al. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. J. Immunol. 182, 871\u2013879 (2009).","journal-title":"J. Immunol."},{"key":"2288_CR36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1099\/vir.0.039065-0","volume":"93","author":"MM Kaminski","year":"2012","unstructured":"Kaminski, M. M., Ohnemus, A., Cornitescu, M. & Staeheli, P. Plasmacytoid dendritic cells and Toll-like receptor 7-dependent signalling promote efficient protection of mice against highly virulent influenza A virus. J. Gen. Virol. 93, 555\u2013559 (2012).","journal-title":"J. Gen. Virol."},{"key":"2288_CR37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4864","volume":"5","author":"S Davidson","year":"2014","unstructured":"Davidson, S., Crotta, S., McCabe, T. M. & Wack, A. Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection. Nat. Commun. 5, 3864 (2014).","journal-title":"Nat. Commun."},{"key":"2288_CR38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.15252\/emmm.201606413","volume":"8","author":"S Davidson","year":"2016","unstructured":"Davidson, S. et al. IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFN\u03b1 treatment. EMBO Mol. Med. 8, 1099\u20131112 (2016).","journal-title":"EMBO Mol. Med."},{"key":"2288_CR39","doi-asserted-by":"crossref","first-page":"e20201631","DOI":"10.1084\/jem.20201631","volume":"218","author":"JCF Rappe","year":"2021","unstructured":"Rappe, J. C. F. et al. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza. J. Exp. Med. 218, e20201631 (2021).","journal-title":"J. Exp. Med."},{"key":"2288_CR40","doi-asserted-by":"crossref","first-page":"20416","DOI":"10.1073\/pnas.0808537105","volume":"105","author":"S Scheu","year":"2008","unstructured":"Scheu, S., Dresing, P. & Locksley, R. M. Visualization of IFN\u03b2 production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl Acad. Sci. USA 105, 20416\u201320421 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2288_CR41","doi-asserted-by":"crossref","first-page":"e98836","DOI":"10.15252\/embj.201798836","volume":"37","author":"E Tomasello","year":"2018","unstructured":"Tomasello, E. et al. Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection. EMBO J. 37, e98836 (2018).","journal-title":"EMBO J."},{"key":"2288_CR42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn3257","volume":"10","author":"F Creusat","year":"2024","unstructured":"Creusat, F. et al. IFN-\u03b3 primes bone marrow neutrophils to acquire regulatory functions in severe viral respiratory infections. Sci. Adv. 10, eadn3257 (2024).","journal-title":"Sci. Adv."},{"key":"2288_CR43","doi-asserted-by":"crossref","first-page":"e101925","DOI":"10.1371\/journal.pone.0101925","volume":"9","author":"H Chen","year":"2014","unstructured":"Chen, H. et al. Pulmonary permeability assessed by fluorescent-labeled dextran instilled intranasally into mice with LPS-induced acute lung injury. PLoS ONE9, e101925 (2014).","journal-title":"PLoS ONE"},{"key":"2288_CR44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"2288_CR45","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045 e1039 (2020).","journal-title":"Cell"},{"key":"2288_CR46","doi-asserted-by":"crossref","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","volume":"5","author":"JS Lee","year":"2020","unstructured":"Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eabd1554 (2020).","journal-title":"Sci. Immunol."},{"key":"2288_CR47","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4906","volume":"7","author":"P Laurent","year":"2022","unstructured":"Laurent, P. et al. Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19. Sci. Immunol. 7, eadd4906 (2022).","journal-title":"Sci. Immunol."},{"key":"2288_CR48","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","volume":"81","author":"PB McCray Jr.","year":"2007","unstructured":"McCray, P. B. Jr. et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81, 813\u2013821 (2007).","journal-title":"J. Virol."},{"key":"2288_CR49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315\u2013320 (2020).","journal-title":"Nature"},{"key":"2288_CR50","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1172\/JCI126363","volume":"129","author":"R Channappanavar","year":"2019","unstructured":"Channappanavar, R. et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J. Clin. Invest. 129, 3625\u20133639 (2019).","journal-title":"J. Clin. Invest."},{"key":"2288_CR51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19, 181\u2013193 (2016).","journal-title":"Cell Host Microbe"},{"key":"2288_CR52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41381-9","volume":"14","author":"TR Ullah","year":"2023","unstructured":"Ullah, T. R. et al. Pharmacological inhibition of TBK1\/IKK\u03b5 blunts immunopathology in a murine model of SARS-CoV-2 infection. Nat. Commun. 14, 5666 (2023).","journal-title":"Nat. Commun."},{"key":"2288_CR53","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.4049\/jimmunol.1303135","volume":"192","author":"M Swiecki","year":"2014","unstructured":"Swiecki, M. et al. Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cells. J. Immunol. 192, 4409\u20134416 (2014).","journal-title":"J. Immunol."},{"key":"2288_CR54","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2011.10.014","volume":"35","author":"H Takagi","year":"2011","unstructured":"Takagi, H. et al. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35, 958\u2013971 (2011).","journal-title":"Immunity"},{"key":"2288_CR55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.09.016","volume":"135","author":"B Cisse","year":"2008","unstructured":"Cisse, B. et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135, 37\u201348 (2008).","journal-title":"Cell"},{"key":"2288_CR56","first-page":"299","volume":"6","author":"TP Vu Manh","year":"2015","unstructured":"Vu Manh, T. P. et al. Defining mononuclear phagocyte subset homology across several distant warm-blooded vertebrates through comparative transcriptomics. Front. Immunol. 6, 299 (2015).","journal-title":"Front. Immunol."},{"key":"2288_CR57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003728","volume":"9","author":"M Swiecki","year":"2013","unstructured":"Swiecki, M., Wang, Y., Gilfillan, S. & Colonna, M. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog. 9, e1003728 (2013).","journal-title":"PLoS Pathog."},{"key":"2288_CR58","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108099","volume":"32","author":"A Jamali","year":"2020","unstructured":"Jamali, A. et al. Characterization of resident corneal plasmacytoid dendritic cells and their pivotal role in herpes simplex keratitis. Cell Rep. 32, 108099 (2020).","journal-title":"Cell Rep."},{"key":"2288_CR59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.immuni.2005.09.016","volume":"23","author":"K Yang","year":"2005","unstructured":"Yang, K. et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-\u03b1\/\u03b2 and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 23, 465\u2013478 (2005).","journal-title":"Immunity"},{"key":"2288_CR60","doi-asserted-by":"crossref","first-page":"e20220514","DOI":"10.1084\/jem.20220514","volume":"219","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Autoantibodies against type I IFNs in patients with critical influenza pneumonia. J. Exp. Med. 219, e20220514 (2022).","journal-title":"J. Exp. Med."},{"key":"2288_CR61","doi-asserted-by":"crossref","first-page":"e56882","DOI":"10.7554\/eLife.56882","volume":"9","author":"SJ Piersma","year":"2020","unstructured":"Piersma, S. J. et al. Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING. Elife 9, e56882 (2020).","journal-title":"Elife"},{"key":"2288_CR62","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1093\/emboj\/17.22.6660","volume":"17","author":"I Marie","year":"1998","unstructured":"Marie, I., Durbin, J. E. & Levy, D. E. Differential viral induction of distinct interferon-\u03b1 genes by positive feedback through interferon regulatory factor-7. EMBO J. 17, 6660\u20136669 (1998).","journal-title":"EMBO J."},{"key":"2288_CR63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbrc.2006.01.122","volume":"342","author":"A Prakash","year":"2006","unstructured":"Prakash, A. & Levy, D. E. Regulation of IRF7 through cell type-specific protein stability. Biochem. Biophys. Res. Commun. 342, 50\u201356 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2288_CR64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2017.01.003","volume":"46","author":"A Brewitz","year":"2017","unstructured":"Brewitz, A. et al. CD8(+) T cells orchestrate pDC-XCR1(+) dendritic cell spatial and functional cooperativity to optimize priming. Immunity 46, 205\u2013219 (2017).","journal-title":"Immunity"},{"key":"2288_CR65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cell.2017.08.024","volume":"171","author":"M Kadoki","year":"2017","unstructured":"Kadoki, M. et al. Organism-level analysis of vaccination reveals networks of protection across tissues. Cell 171, 398\u2013413 e321 (2017).","journal-title":"Cell"},{"key":"2288_CR66","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature17655","volume":"532","author":"LK Beura","year":"2016","unstructured":"Beura, L. K. et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512\u2013516 (2016).","journal-title":"Nature"},{"key":"2288_CR67","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.chom.2016.04.003","volume":"19","author":"TA Reese","year":"2016","unstructured":"Reese, T. A. et al. Sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response. Cell Host Microbe 19, 713\u2013719 (2016).","journal-title":"Cell Host Microbe"},{"key":"2288_CR68","doi-asserted-by":"crossref","first-page":"e20201387","DOI":"10.1084\/jem.20201387","volume":"218","author":"F Onodi","year":"2021","unstructured":"Onodi, F. et al. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. J. Exp. Med. 218, e20201387 (2021).","journal-title":"J. Exp. Med."},{"key":"2288_CR69","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"2288_CR70","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36140-9","volume":"14","author":"M Venet","year":"2023","unstructured":"Venet, M. et al. Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2. Nat. Commun. 14, 694 (2023).","journal-title":"Nat. Commun."},{"key":"2288_CR71","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/aid.2012.0313","volume":"29","author":"M Buitendijk","year":"2013","unstructured":"Buitendijk, M., Eszterhas, S. K. & Howell, A. L. Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells. AIDS Res. Hum. Retroviruses 29, 907\u2013918 (2013).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"2288_CR72","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/biology10070661","volume":"10","author":"FZ Meng","year":"2021","unstructured":"Meng, F. Z. et al. TLR7 activation of macrophages by imiquimod inhibits HIV infection through modulation of viral entry cellular factors. Biology 10, 661 (2021).","journal-title":"Biology"},{"key":"2288_CR73","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3390\/v13091839","volume":"13","author":"TT Greene","year":"2021","unstructured":"Greene, T. T. & Zuniga, E. I. Type I interferon induction and exhaustion during viral infection: plasmacytoid dendritic cells and emerging COVID-19 Findings. Viruses 13, 1839 (2021).","journal-title":"Viruses"},{"key":"2288_CR74","doi-asserted-by":"crossref","first-page":"e1003915","DOI":"10.1371\/journal.ppat.1003915","volume":"10","author":"T Bruel","year":"2014","unstructured":"Bruel, T. et al. Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques. PLoS Pathog. 10, e1003915 (2014).","journal-title":"PLoS Pathog."},{"key":"2288_CR75","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1172\/JCI130597","volume":"130","author":"JL Mitchell","year":"2020","unstructured":"Mitchell, J. L. et al. Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption. J. Clin. Invest. 130, 2845\u20132858 (2020).","journal-title":"J. Clin. Invest."},{"key":"2288_CR76","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"2288_CR77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02288-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:20:02Z","timestamp":1761787202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02288-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":77,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2288"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02288-3","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.F., B.M., A.Z., M.D. and E.T. are inventors on a patent application filed on the targeting of pDCs to treat certain respiratory viral infections. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}